• 2024
  Jeger-Madiot R, Planas D, Staropoli I, Debarnot H, Kervevan J, Mary H, Collina C, Fonseca BF, Robinot R, Gellenoncourt S, Schwartz O, Ewart L, Bscheider M, Gobaa S, Chakrabarti LA, Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting., J Exp Med 2024 Oct; 221(10): .
• 2024
  White E, Papagno L, Samri A, Sugata K, Hejblum B, Henry AR, Rogan DC, Darko S, Recordon-Pinson P, Dudoit Y, Llewellyn-Lacey S, Chakrabarti LA, Buseyne F, Migueles SA, Price DA, Andreola MA, Satou Y, Thiebaut R, Katlama C, Autran B, Douek DC, Appay V, Clonal succession after prolonged antiretroviral therapy rejuvenates CD8+ T cell responses against HIV-1., Nat Immunol 2024 Sep; 25(9): 1555-1564.
• 2023
  Zhou B, Zhou R, Chan JF, Zeng J, Zhang Q, Yuan S, Liu L, Robinot R, Shan S, Liu N, Ge J, Kwong HY, Zhou D, Xu H, Chan CC, Poon VK, Chu H, Yue M, Kwan KY, Chan CY, Chan CC, Chik KK, Du Z, Au KK, Huang H, Man HO, Cao J, Li C, Wang Z, Zhou J, Song Y, Yeung ML, To KK, Ho DD, Chakrabarti LA, Wang X, Zhang L, Yuen KY, Chen Z, SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters1., Emerg Microbes Infect 2023 Dec; 12(2): 2245921.
• 2023
  Volle R, Luo L, Razafindratsimandresy R, Sadeuh-Mba SA, Gouandjika-Valisache I, Horwood P, Duong V, Buchy P, Joffret ML, Huang Z, Duizer E, Martin J, Chakrabarti LA, Dussart P, Jouvenet N, Delpeyroux F, Bessaud M, Neutralization of African enterovirus A71 genogroups by antibodies to canonical genogroups., J Gen Virol 2023 Nov; 104(11): .
• 2023
  Vaid R, Mendez A, Thombare K, Burgos-Panadero R, Robinot R, Fonseca BF, Gandasi NR, Ringlander J, Hassan Baig M, Dong JJ, Cho JY, Reinius B, Chakrabarti LA, Nystrom K, Mondal T, Global loss of cellular m6A RNA methylation following infection with different SARS-CoV-2 variants., Genome Res 2023 Mar; 33(3): 299-313.
• 2023
  Kervevan J, Staropoli I, Slama D, Jeger-Madiot R, Donnadieu F, Planas D, Pietri MP, Loghmari-Bouchneb W, Alaba Tanah M, Robinot R, Boufassa F, White M, Salmon-Ceron D, Chakrabarti LA, Divergent adaptive immune responses define two types of long COVID., Front Immunol 2023 ; 14(): 1221961.
• 2022
  Gellenoncourt S, Saunders N, Robinot R, Auguste L, Rajah MM, Kervevan J, Jeger-Madiot R, Staropoli I, Planchais C, Mouquet H, Buchrieser J, Schwartz O, Chakrabarti LA, , The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants., J Virol 2022 Oct; 96(19): e0130122.
• 2022
  Fonseca BF, Chakrabarti LA, , A close shave: How SARS-CoV-2 induces the loss of cilia., J Cell Biol 2022 Jul; 221(7): .
• 2022
  Chen SMY, Wong YC, Yim LY, Zhang H, Wang H, Lui GCY, Li X, Tang X, Cheng L, Du Y, Peng Q, Wang J, Kwok HY, Huang H, Lau TT, Chan DPC, Wong BCK, Liu L, Chakrabarti LA, Lee SS, Chen Z, , Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine., J Virol 2022 04; 96(7): e0216121.
• 2022
  Claireaux M, Robinot R, Kervevan J, Patgaonkar M, Staropoli I, Brelot A, Nouël A, Gellenoncourt S, Tang X, Héry M, Volant S, Perthame E, Avettand-Fenoël V, Buchrieser J, Cokelaer T, Bouchier C, Ma L, Boufassa F, Hendou S, Libri V, Hasan M, Zucman D, de Truchis P, Schwartz O, Lambotte O, Chakrabarti LA, , Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry., Nat Commun 2022 Jan; 13(1): 521.
• 2022
  Samelson AJ, Tran QD, Robinot R, Carrau L, Rezelj VV, Kain AM, Chen M, Ramadoss GN, Guo X, Lim SA, Lui I, Nuñez JK, Rockwood SJ, Wang J, Liu N, Carlson-Stevermer J, Oki J, Maures T, Holden K, Weissman JS, Wells JA, Conklin BR, TenOever BR, Chakrabarti LA, Vignuzzi M, Tian R, Kampmann M, , BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2., Nat Cell Biol 2022 01; 24(1): 24-34.
• 2021
  Rajah MM, Hubert M, Bishop E, Saunders N, Robinot R, Grzelak L, Planas D, Dufloo J, Gellenoncourt S, Bongers A, Zivaljic M, Planchais C, Guivel-Benhassine F, Porrot F, Mouquet H, Chakrabarti LA, Buchrieser J, Schwartz O, , SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation., EMBO J 2021 12; 40(24): e108944.
• 2021
  Meyer B, Chiaravalli J, Gellenoncourt S, Brownridge P, Bryne DP, Daly LA, Grauslys A, Walter M, Agou F, Chakrabarti LA, Craik CS, Eyers CE, Eyers PA, Gambin Y, Jones AR, Sierecki E, Verdin E, Vignuzzi M, Emmott E, , Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential., Nat Commun 2021 09; 12(1): 5553.
• 2021
  Robinot R, Hubert M, de Melo GD, Lazarini F, Bruel T, Smith N, Levallois S, Larrous F, Fernandes J, Gellenoncourt S, Rigaud S, Gorgette O, Thouvenot C, Trébeau C, Mallet A, Duménil G, Gobaa S, Etournay R, Lledo PM, Lecuit M, Bourhy H, Duffy D, Michel V, Schwartz O, Chakrabarti LA, SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance., Nat Commun 2021 Jul; 12(1): 4354.
• 2021
  Wong YC, Liu W, Yim LY, Li X, Wang H, Yue M, Niu M, Cheng L, Ling L, Du Y, Chen SMY, Cheung KW, Wang H, Tang X, Tang J, Zhang H, Song Y, Chakrabarti LA, Chen Z, , Sustained viremia suppression by SHIVSF162P3CN-recalled effector-memory CD8+ T cells after PD1-based vaccination., PLoS Pathog 2021 06; 17(6): e1009647.
• 2021
  Kervevan J, Chakrabarti LA, , Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions., Int J Mol Sci 2021 Jan; 22(2): .
• 2020
  Tang X, Zhang S, Peng Q, Ling L, Shi H, Liu Y, Cheng L, Xu L, Cheng L, Chakrabarti LA, Chen Z, Wang H, Zhang Z, , Sustained IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection., Sci Adv 2020 02; 6(8): eaaz0374.
• 2019
  Moris A, Pereira M, Chakrabarti L, A role for antibodies in natural HIV control, Curr Opin HIV AIDS 2019 Apr;.
• 2018
  Brelot A, Chakrabarti LA, CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis, J. Mol. Biol. 2018 Aug;430(17):2557-2589.
• 2018
  Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, Tan LL, Ciacchi L, Reid HH, Rossjohn J, Chakrabarti LA, Gras S, CD4 T cell-mediated HLA class II cross-restriction in HIV controllers, Sci Immunol 2018 06;3(24).
• 2018
  Claireaux M, Galperin M, Benati D, Nouël A, Mukhopadhyay M, Klingler J, de Truchis P, Zucman D, Hendou S, Boufassa F, Moog C, Lambotte O, Chakrabarti LA, A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers, MBio 2018 May;9(3).
• 2017
  Mukhopadhyay M, Galperin M, Patgaonkar M, Vasan S, Ho DD, Nouël A, Claireaux M, Benati D, Lambotte O, Huang Y, Chakrabarti LA, DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers, J. Immunol. 2017 Nov;199(10):3437-3452.
• 2016
  Benati D, Galperin M, Lambotte O, Gras S, Lim A, Mukhopadhyay M, Nouël A, Campbell KA, Lemercier B, Claireaux M, Hendou S, Lechat P, de Truchis P, Boufassa F, Rossjohn J, Delfraissy JF, Arenzana-Seisdedos F, Chakrabarti LA, Public T cell receptors confer high-avidity CD4 responses to HIV controllers, J. Clin. Invest. 2016 Apr;.
• 2016
  Lissina A, Chakrabarti LA, Takiguchi M, Appay V, TCR clonotypes: molecular determinants of T-cell efficacy against HIV, Curr Opin Virol 2016 Feb;16:77-85.
• 2015
  Chakrabarti LA, Lortholary O, [IRIS: a paradoxical inflammatory reaction in patients treated simultaneously for tuberculosis and HIV], Med Sci (Paris) 2015 Jan;31(1):53-9.
• 2014
  Chakrabarti LA, Boucherie C, Bugault F, Cumont MC, Roussillon C, Breton G, Patey O, Chêne G, Richert L, Lortholary O, , Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome, AIDS 2014 Jul;28(11):1593-602.
• 2013
  Granier C, Battivelli E, Lécuroux C, Venet A, Lambotte O, Schmitt-Boulanger M, Delaugerre C, Molina JM, Chakrabarti LA, Clavel F, Hance AJ, Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles, J. Virol. 2013 Sep;87(18):10368-80.
• 2013
  Bugault F, Benati D, Mouthon L, Landires I, Rohrlich P, Pestre V, Thèze J, Lortholary O, Chakrabarti LA, Altered responses to homeostatic cytokines in patients with idiopathic CD4 lymphocytopenia, PLoS ONE 2013;8(1):e55570.
• 2012
  Vingert B, Benati D, Lambotte O, de Truchis P, Slama L, Jeannin P, Galperin M, Perez-Patrigeon S, Boufassa F, Kwok WW, Lemaître F, Delfraissy JF, Thèze J, Chakrabarti LA, HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term, J. Virol. 2012 Oct;86(19):10661-74.
• 2011
  Landires I, Bugault F, Lambotte O, de Truchis P, Slama L, Danckaert A, Delfraissy JF, Thèze J, Chakrabarti LA, HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization, AIDS 2011 Sep;25(15):1843-53.
• 2011
  Thèze J, Chakrabarti LA, Vingert B, Porichis F, Kaufmann DE, HIV controllers: a multifactorial phenotype of spontaneous viral suppression, Clin. Immunol. 2011 Oct;141(1):15-30.
• 2011
  Boufassa F, Saez-Cirion A, Lechenadec J, Zucman D, Avettand-Fenoel V, Venet A, Rouzioux C, Delfraissy JF, Lambotte O, Meyer L, , CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory, PLoS ONE 2011;6(4):e18726.
• 2011
  Thèze J, Chakrabarti L, Vingert B, Lambotte O, Delfraissy JF, [Role of CD4 lymphocytes in the efficient immune response of HIV controllers], Bull. Acad. Natl. Med. 2011 Mar;195(3):545-57; discussion 557-9.
• 2010
  Chakrabarti LA, Simon V, Immune mechanisms of HIV control, Curr. Opin. Immunol. 2010 Aug;22(4):488-96.
• 2010
  Vingert B, Perez-Patrigeon S, Jeannin P, Lambotte O, Boufassa F, Lemaître F, Kwok WW, Theodorou I, Delfraissy JF, Thèze J, Chakrabarti LA, , HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity, PLoS Pathog. 2010 Feb;6(2):e1000780.
• 2010
  Juffroy O, Bugault F, Lambotte O, Landires I, Viard JP, Niel L, Fontanet A, Delfraissy JF, Thèze J, Chakrabarti LA, Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway, J. Virol. 2010 Jan;84(1):96-108.
• 2009
  Scott-Algara D, Balabanian K, Chakrabarti LA, Mouthon L, Dromer F, Didier C, Arenzana-Seisdedos F, Lortholary O, Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4, Blood 2010 May;115(18):3708-17.
• 2009
  Perez-Patrigeon S, Vingert B, Lambotte O, Viard JP, Delfraissy JF, Thèze J, Chakrabarti LA, HIV infection impairs CCR7-dependent T-cell chemotaxis independent of CCR7 expression, AIDS 2009 Jun;23(10):1197-207.
• 2009
  Pillet AH, Bugault F, Thèze J, Chakrabarti LA, Rose T, A programmed switch from IL-15- to IL-2-dependent activation in human NK cells, J. Immunol. 2009 May;182(10):6267-77.
• 2007
  Potter SJ, Lacabaratz C, Lambotte O, Perez-Patrigeon S, Vingert B, Sinet M, Colle JH, Urrutia A, Scott-Algara D, Boufassa F, Delfraissy JF, Thèze J, Venet A, Chakrabarti LA, Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study, J. Virol. 2007 Dec;81(24):13904-15.
• 2007
  Tasca S, Tsai L, Trunova N, Gettie A, Saifuddin M, Bohm R, Chakrabarti L, Cheng-Mayer C, Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure, Virology 2007 Oct;367(1):196-211.
• 2006
  Sáez-Cirión A, Versmisse P, Truong LX, Chakrabarti LA, Carpentier W, Barré-Sinoussi F, Scott-Algara D, Pancino G, Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks, Retrovirology 2006;3:81.
• 2004
  Balabanian K, Harriague J, Décrion C, Lagane B, Shorte S, Baleux F, Virelizier JL, Arenzana-Seisdedos F, Chakrabarti LA, CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes, J. Immunol. 2004 Dec;173(12):7150-60.
• 2004
  Chakrabarti LA, The paradox of simian immunodeficiency virus infection in sooty mangabeys: active viral replication without disease progression, Front. Biosci. 2004 Jan;9:521-39.
• 2003
  Chakrabarti LA, Metzner KJ, Ivanovic T, Cheng H, Louis-Virelizier J, Connor RI, Cheng-Mayer C, A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication, J. Virol. 2003 Jan;77(2):1245-56.
• 2002
  Mulder LC, Chakrabarti LA, Muesing MA, Interaction of HIV-1 integrase with DNA repair protein hRad18, J. Biol. Chem. 2002 Jul;277(30):27489-93.
• 2002
  Chakrabarti LA, Ivanovic T, Cheng-Mayer C, Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones, J. Virol. 2002 Feb;76(4):1588-99.
• 2001
  Chakrabarti LA, Luckay A, Marx PA, A divergent simian immunodeficiency virus from sooty mangabey with an atypical Tat-TAR structure, AIDS Res. Hum. Retroviruses 2001 Aug;17(12):1155-65.
• 2000
  Chakrabarti LA, Lewin SR, Zhang L, Gettie A, Luckay A, Martin LN, Skulsky E, Ho DD, Cheng-Mayer C, Marx PA, Age-dependent changes in T cell homeostasis and SIV load in sooty mangabeys, J. Med. Primatol. 2000 Aug;29(3-4):158-65.
• 2000
  Chakrabarti LA, Lewin SR, Zhang L, Gettie A, Luckay A, Martin LN, Skulsky E, Ho DD, Cheng-Mayer C, Marx PA, Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection, J. Virol. 2000 Feb;74(3):1209-23.
• 1998
  Rey-Cuillé MA, Berthier JL, Bomsel-Demontoy MC, Chaduc Y, Montagnier L, Hovanessian AG, Chakrabarti LA, Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease, J. Virol. 1998 May;72(5):3872-86.
• 1996
  Khatissian E, Monceaux V, Cumont MC, Montagnier L, Hurtrel B, Chakrabarti L, Interferon-gamma expression in macaque lymph nodes during primary infection with simian immunodeficiency virus, Cytokine 1996 Nov;8(11):844-52.
• 1996
  Khatissian E, Tovey MG, Cumont MC, Monceaux V, Lebon P, Montagnier L, Hurtrel B, Chakrabarti L, The relationship between the interferon alpha response and viral burden in primary SIV infection, AIDS Res. Hum. Retroviruses 1996 Sep;12(13):1273-8.
• 1996
  Khatissian E, Chakrabarti L, Hurtrel B, Cytokine patterns and viral load in lymph nodes during the early stages of SIV infection, Res. Virol. 1996 Mar-Jun;147(2-3):181-9.
• 1995
  Boche D, Gray F, Chakrabarti L, Hurtrel M, Montagnier L, Hurtrel B, Low susceptibility of resident microglia to simian immunodeficiency virus replication during the early stages of infection, Neuropathol. Appl. Neurobiol. 1995 Dec;21(6):535-9.
• 1995
  Chakrabarti L, Baptiste V, Khatissian E, Cumont MC, Aubertin AM, Montagnier L, Hurtrel B, Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus, Virology 1995 Nov;213(2):535-48.
• 1995
  Denesvre C, Le Grand R, Boissin-Cans F, Chakrabarti L, Hurtrel B, Vaslin B, Dormont D, Sonigo P, Highly attenuated SIVmac142 is immunogenic but does not protect against SIVmac251 challenge, AIDS Res. Hum. Retroviruses 1995 Nov;11(11):1397-406.
• 1994
  Bach JM, Hurtrel M, Chakrabarti L, Ganiere JP, Montagnier L, Hurtrel B, Early stages of feline immunodeficiency virus infection in lymph nodes and spleen, AIDS Res. Hum. Retroviruses 1994 Dec;10(12):1731-8.
• 1994
  Khatissian E, Chakrabarti L, Hurtrel B, Cytokine patterns in lymph nodes during the early stages of simian immunodeficiency virus infection, Res. Immunol. 1994 Oct-Dec;145(8-9):702-5.
• 1994
  Chakrabarti L, Cumont MC, Montagnier L, Hurtrel B, Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression, J. Virol. 1994 Oct;68(10):6634-43.
• 1994
  Chakrabarti L, Isola P, Cumont MC, Claessens-Maire MA, Hurtrel M, Montagnier L, Hurtrel B, Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells, Am. J. Pathol. 1994 Jun;144(6):1226-37.
• 1994
  Hurtrel B, Chakrabarti L, Hurtrel M, Bach JM, Ganière JP, Montagnier L, Early events in lymph nodes during infection with SIV and FIV, Res. Virol. 1994 May-Aug;145(3-4):221-7.
• 1994
  Chakrabarti L, Cumont MC, Montagnier L, Hurtrel B, Kinetics of primary SIV infection in lymph nodes, J. Med. Primatol. 1994 Feb-May;23(2-3):117-24.
• 1993
  Hurtrel B, Chakrabarti L, Hurtrel M, Montagnier L, Target cells during early SIV encephalopathy, Res. Virol. 1993 Jan-Feb;144(1):41-6.
• 1992
  Hurtrel M, Ganière JP, Guelfi JF, Chakrabarti L, Maire MA, Gray F, Montagnier L, Hurtrel B, Comparison of early and late feline immunodeficiency virus encephalopathies, AIDS 1992 Apr;6(4):399-406.
• 1991
  Chakrabarti L, Hurtrel M, Maire MA, Vazeux R, Dormont D, Montagnier L, Hurtrel B, Early viral replication in the brain of SIV-infected rhesus monkeys, Am. J. Pathol. 1991 Dec;139(6):1273-80.
• 1991
  Hurtrel B, Chakrabarti L, Hurtrel M, Maire MA, Dormont D, Montagnier L, Early SIV encephalopathy, J. Med. Primatol. 1991 Jun;20(4):159-66.
• 1989
  Chakrabarti L, Emerman M, Tiollais P, Sonigo P, The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity, J. Virol. 1989 Oct;63(10):4395-403.
• 1987
  Chakrabarti L, Guyader M, Alizon M, Daniel MD, Desrosiers RC, Tiollais P, Sonigo P, Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses, Nature 1987 Aug 6-12;328(6130):543-7.